Core Scientific, Inc. (CORZ) stock price, news, quote and history
This page provides a comprehensive overview of Core Scientific, Inc. (CORZ) stock, including its current price, after-hours trading, historical data, and key financial metrics. It details the company's operations in high-density colocation and digital asset mining, along with recent news, performance against benchmarks, earnings trends, and analyst ratings, including a recent price target increase by Canaccord Genuity. The page also features valuation measures, financial highlights, and comparisons with similar companies in the Software—Infrastructure industry.
Why Core Scientific (CORZ) Is Up 7.7% After Doubling Its Delayed-Draw Credit Facility To $1 Billion
Core Scientific (CORZ) increased its Delayed-Draw Bridge Credit Facility by $500 million to $1 billion, enhancing its financial flexibility for high-performance computing (HPC) projects. This expansion is crucial for funding its updated CoreWeave agreement, which targets nearly 900 MW of contracted HPC capacity. While the increased leverage poses some risk, the move is expected to support the company's growth narrative and its transition from Bitcoin mining to HPC.
FNY Investment Advisers LLC Acquires New Shares in Core Scientific, Inc. $CORZ
FNY Investment Advisers LLC initiated a new position in Core Scientific, Inc. (NASDAQ:CORZ) during Q4, purchasing 86,040 shares valued at approximately $1.25 million. Other institutional investors also increased their stakes, with SG Americas Securities LLC boosting its holdings by 624.4% to 983,430 shares. Core Scientific reported Q4 EPS of $0.42, exceeding consensus, though revenue of $79.76 million missed estimates and was down 16% year-over-year.
Core Scientific, Inc. (NASDAQ:CORZ) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Core Scientific, Inc. (NASDAQ:CORZ) has received a "Moderate Buy" consensus recommendation from analysts, with an average one-year price target of $24.84. This comes after the company reported an EPS beat of $0.42 against an estimated -$0.27, although revenue of $79.76 million missed estimates. Insider Todd M. Duchene sold 10,000 shares, and institutional investors have adjusted their holdings.
Core Scientific (CORZ) officer sells 10,000 shares under trading plan
Core Scientific, Inc. officer Todd M. Duchene sold 10,000 shares of common stock at a weighted average price of $15.2523 per share under a pre-arranged Rule 10b5-1 trading plan. This transaction followed the settlement of 216,734 performance-based restricted stock units and the withholding of 97,652 shares for tax obligations. After these transactions, Duchene directly holds 2,047,089 shares of Core Scientific common stock.
Core Scientific (CORZ) CEO receives PSU shares, withholds stock for taxes
Core Scientific, Inc. CEO Adam Taylor received 741,545 Common Stock shares from vested performance-based restricted stock units (PSUs) on March 31, 2026. Concurrently, 315,307 shares were withheld at $14.96 per share to cover tax obligations related to the PSU vesting. These transactions reflect routine compensation and tax settlement and are not considered open-market trades, bringing Taylor's direct holdings to 4,557,388 shares.
Core Scientific’s DuChene sells $152,523 in stock
Todd M. DuChene, Chief Legal and Administrative Officer at Core Scientific, Inc., sold 10,000 shares of company stock for $152,523 on April 1, 2026, under a pre-arranged trading plan. This sale followed his acquisition of 216,734 shares as part of a performance-based grant and the withholding of 97,652 shares for tax obligations. The transaction occurred amidst significant company developments including a new $500 million credit facility, analyst rating upgrades, and strategic expansion efforts.
Cost of goods sold of Core Scientific, Inc. - Tranche 1 – NASDAQ:CORZW
This article focuses on the cost of goods sold for Core Scientific, Inc. - Tranche 1 (NASDAQ: CORZW). It provides a financial overview and notes that market data is provided by ICE Data Services and FactSet. The content is primarily a financial data point placeholder from TradingView, indicating no specific values are present but the category is available for the company.
Discontinued operations of Core Scientific, Inc. - Tranche 1 – NASDAQ:CORZW
This article briefly lists the "Discontinued operations of Core Scientific, Inc. - Tranche 1" for the NASDAQ:CORZW stock. It provides market data information and highlights the financial overview of the company's discontinued operations. The content is very minimal, presenting only the title of the discontinued operations and basic market data references.
Mixed options sentiment in Core Scientific, Inc with shares up 1.7%
Core Scientific, Inc (CORZ) experienced mixed options sentiment with its shares increasing by 1.7% to $15.21. Options trading volume was relatively light, with puts leading calls at a ratio of 1.7, compared to a typical 0.65. Implied volatility dropped, suggesting a daily expected move of $0.77, and the put-call skew flattened, indicating a modestly bullish outlook.
[ARS] Core Scientific, Inc./tx SEC Filing
This article announces an ARS SEC filing by Core Scientific, Inc./tx (CORZ) on March 31, 2026, which is available as a PDF document. It also provides an overview of Core Scientific's stock, recent news, and other SEC filings, including a strategic financing facility expansion and Q4 2025 results. The company's market cap is 5.12 billion.
Mixed options sentiment in Core Scientific, Inc with shares up 7.55%
Core Scientific, Inc (CORZ) saw its shares rise by 7.55% to near $14.96, despite a mixed options sentiment. While options volume was relatively light at 88k contracts, calls outnumbered puts with a put/call ratio of 0.7, slightly higher than the typical 0.64. The implied volatility (IV30) decreased to 83.91, suggesting an expected daily move of $0.79, and the put-call skew steepened, indicating increased demand for downside protection.
Core Scientific (CORZ) Shares Up Slightly Since Jim Cramer Advised To “Ring the Register”
Core Scientific (CORZ) shares have increased slightly since Jim Cramer advised investors to "ring the register" in July, despite recent drops in November and December and a year-to-date decline. The company, a major Bitcoin mining firm pivoting to high-performance computing, faced setbacks such as the cancellation of its merger with CoreWeave and a 7.2% decline after its Q4 earnings report. Cramer's earlier advice stemmed from the then-expected merger, suggesting a sale for immediate gains.
Why Core Scientific Stock Is Suddenly Sinking
Core Scientific (CORZ) stock is declining due to investors moving away from crypto-related assets as Bitcoin struggles and geopolitical tensions rise. Further pressure comes from de-risking ahead of a Federal Reserve Chair speech, impacting high-beta digital asset miners. Concerns over increased leverage from an expanded credit facility and heavy capital spending for AI data center infrastructure are also contributing to the negative sentiment.
JPMorgan Chase & Co. Sells 313,009 Shares of Core Scientific, Inc. $CORZ
JPMorgan Chase & Co. reduced its stake in Core Scientific by 36.7% in the third quarter, selling 313,009 shares and retaining 539,194 shares valued at $9.67 million. This comes as Core Scientific reported mixed quarterly results, beating EPS estimates but missing on revenue, with its stock down approximately 4.6%. Analysts currently hold a "Moderate Buy" rating for the company with an average price target of $24.84, despite varied individual broker ratings.
[Form 4/A] Core Scientific, Inc./tx Amended Insider Trading Activity
Core Scientific EVP and CFO James P. Nygaard Jr. filed an amended Form 4 (4/A) to correct a previous insider trading report. The amendment clarifies that 98,671 shares of Common Stock were withheld at $16.42 per share on March 26, 2026, to cover tax obligations related to the vesting of restricted stock units. This transaction was a mechanical tax payment, not an open-market sale, and Nygaard now directly holds 922,982 shares.
Mixed options sentiment in Core Scientific, Inc with shares down 2.47%
Core Scientific, Inc. (CORZ) is experiencing mixed options sentiment as its shares declined by 2.47% to approximately $15.40. Options trading volume was relatively light, with calls outnumbering puts, indicating a put/call ratio of 0.19, which is lower than the typical level of 0.63. The implied volatility (IV30) decreased to 82.54, suggesting a daily expected move of $0.80, and the put-call skew flattened, hinting at a modestly bullish outlook.
CoreWeave Partner Core Scientific's Stock Jumps In Momentum After $1 Billion Financing Deal
Core Scientific (NASDAQ: CORZ) has seen its stock momentum score rise significantly, placing it in the top 10% for relative strength, following secured financing of $1 billion for its AI data center pivot. This capital, including a $500 million commitment from JPMorgan Chase, will fund property acquisitions and equipment to convert Bitcoin mining sites into high-performance computing centers. Analysts like BTIG view the company as undervalued, with a "Buy" rating and a $23.00 price target, despite short-term fluctuations, highlighting its long-term positive trend and 106.95% gain over the past year.
[SCHEDULE 13G/A] Core Scientific, Inc./tx Amended Passive Investment Disclosure
The Vanguard Group filed an Amended Schedule 13G/A for Core Scientific Inc., reporting 0 beneficially owned shares of Common Stock as of March 13, 2026. This amendment reflects an internal realignment on January 12, 2026, which disaggregated certain Vanguard subsidiaries' holdings from The Vanguard Group, Inc., resulting in Vanguard's ownership being below 5%. The filing certifies sole and shared voting and dispositive powers of 0 shares.
Core Scientific Inc (CORZ) Shares Gap Down to $16.285 on Mar 26
Core Scientific Inc (CORZ) shares dropped 4.49% to $16.29 on March 26, reaching an intraday low of $16.21. This places the stock significantly above its 52-week low but still below its 52-week high. Wall Street analysts maintain an "Outperform" rating with an average target price of $26.10, indicating a potential upside of over 60%.
Selling pressure pushes Core Scientific stock lower in today's trading
Core Scientific (CORZ) saw its stock fall by 3.78% to $16.41, trading between key support and resistance levels. While short-term technicals show mixed signals with potential for both bullish and bearish movements, experts from Traders Union highlight the ongoing struggle between buyers and sellers. Upcoming volatility is expected, with a critical level for a potential upside breakout identified at $17.04.
Silverleafe Capital Partners LLC Acquires New Stake in Core Scientific, Inc. $CORZ
Silverleafe Capital Partners LLC has acquired a new stake of 72,950 shares in Core Scientific (NASDAQ:CORZ), valued at approximately $1.062 million, during Q4. Core Scientific reported a Q4 EPS of $0.42, surpassing estimates, though revenue of $79.76 million missed forecasts and saw a 16% year-over-year decline. Analyst sentiment for Core Scientific is largely positive, with a "Moderate Buy" consensus rating and an average target price of $24.84.
Why Core Scientific (CORZ) is one of the best strong buy stocks to invest in under $20
The article analyzes why Core Scientific (CORZ) is considered a strong buy stock, particularly for investors looking for opportunities under $20. It delves into the factors contributing to its strong buy rating and potential for investment.
Why Core Scientific (CORZ) is One of the Best Strong Buy Stocks to Invest in Under $20
Core Scientific (CORZ) is highlighted as a strong buy stock under $20, particularly following its announcement of an additional $500 million commitment, increasing its total financing capacity to $1.0 billion. The company, which operates in digital Bitcoin mining and high-performance computing, plans to use these funds for data center development and infrastructure expansion. The article emphasizes CORZ's position to capitalize on strong demand, though it also mentions other AI stocks with potentially higher and faster returns.
How Core Scientific’s Expanded US$1 Billion Credit Facility Could Reshape Core Scientific (CORZ) Investors
Core Scientific, Inc. has doubled its delayed-draw bridge credit agreement to US$1 billion, drawing the additional US$500 million to fund data center infrastructure. This move intensifies the company's pivot from Bitcoin mining to AI and high-performance computing, backed by lenders like Morgan Stanley and JPMorgan. The expanded facility boosts data center capacity build-out, but also increases leverage and capital deployment risks for investors.
Why is Core Scientific stock up today?
Core Scientific Inc. (CORZ) stock is up 5.44% today, trading at $16.67. Despite this short-term gain, the stock is in a medium-term downtrend, with mixed technical signals and analysts offering differing views on its future direction. While some see potential for further growth if key resistance levels are broken, others highlight the lack of strong positive momentum and the fragility of current sentiment.
Core Scientific Expands Bridge Term Loan by $500 Million to $1.0 Billion, Draws Full Amount
Core Scientific (CORZ) has expanded its delayed-draw bridge credit agreement by $500 million, increasing its total term loan capacity to $1.0 billion. The company immediately drew the full $500 million on March 18, 2026, to bolster its liquidity for corporate needs and ongoing initiatives. This facility is administered by Morgan Stanley Senior Funding, with JPMorgan Chase Bank participating as a key lender.
Core Scientific (NASDAQ: CORZ) lifts credit facility to $1B with $500M add-on
Core Scientific (NASDAQ: CORZ) has significantly expanded its short-term credit facility to $1 billion by adding an extra $500 million under an accordion feature. The company borrowed the full incremental amount, which is priced at SOFR plus 250 basis points. These funds are earmarked for general corporate purposes, specifically to support the development of data center assets, including equipment purchases, real estate acquisitions, and energy procurement for high-density colocation and AI-focused infrastructure.
Bitcoin mining and infrastructure provider Core Scientific, Inc. announced that it has increased the total amount of its strategic financing arrangements to 1 billion dollars.
Core Scientific, a Bitcoin mining and infrastructure provider, has increased its strategic financing arrangements to $1 billion. This expansion includes a new $500 million commitment from JPMorgan, which will be used to grow its high-performance computing business and accelerate blockchain infrastructure deployment. The company aims to maintain its technological leadership and optimize its capital structure to strengthen its market position and prepare for future growth in the cryptocurrency industry.
Two Seas Capital details 5.5% Core Scientific (CORZ) ownership stake
Two Seas Capital and its affiliates have reported an amended Schedule 13D, disclosing beneficial ownership of 17,466,679 shares of Core Scientific (CORZ) common stock, which represents approximately 5.5% of the outstanding shares. This filing includes shares issuable from warrants and options and also updates a Cooperation Agreement, waiving a requirement for Core Scientific to appoint an independent director by March 15, 2026, provided the appointment is made by May 30, 2026. The funds and accounts managed by Two Seas Capital maintain economic interests, while voting and investment power are delegated to Two Seas Capital.
Book value per share of Core Scientific, Inc. - Tranche 1 – NASDAQ:CORZW
This page provides financial information for Core Scientific, Inc. - Tranche 1 (NASDAQ: CORZW), specifically focusing on its book value per share. It appears to be a stub or an overview page from TradingView, directing users to more detailed financials, news, and community discussions. It also highlights various products and community features offered by TradingView.
Core Scientific (CORZ) CFO has 92,725 shares withheld for RSU tax
Core Scientific (CORZ) CFO James P. Nygaard Jr. had 92,725 shares withheld at $16.42 per share on March 17, 2026, to cover tax obligations from vested restricted stock units. This transaction, coded as an 'F' for tax withholding, is not an open-market sale and provides limited insight into the insider's view of the stock. Following this, Nygaard directly owns 928,928 shares of Core Scientific common stock.
Core Scientific (NASDAQ: CORZ) updates 10-K to add incentive pay clawback exhibit
Core Scientific, Inc. (NASDAQ: CORZ) has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The amendment's sole purpose is to include Exhibit 97.1, its Policy on Recoupment of Incentive Compensation, which was inadvertently omitted from the original filing. This amendment clarifies that no financial or other disclosures from the initial report have been altered.
Is Core Scientific (CORZ) Using the Cadillac F1 Deal to Redefine Its High-Performance Computing Story?
Core Scientific (CORZ) has partnered with the Cadillac Formula 1 Team, positioning itself as the team’s Official Data Center Partner to showcase its high-performance computing capabilities beyond digital asset mining. This collaboration, along with a recent US$500 million loan from Morgan Stanley for data center expansion, aims to redefine the company's investment narrative towards high-performance computing. However, investors are advised to monitor the execution risk associated with scaling new HPC capacity and concentration risk revolving around CoreWeave.
Is Core Scientific (CORZ) One of the Best Crypto Stocks with Huge Upside Potential?
Core Scientific (CORZ) is highlighted as a crypto stock with significant upside potential, corroborated by Citizens reiterating a "Market Outperform" rating and a $30 price target. The company is strategically shifting from Bitcoin mining to high-performance computing (HPC), securing a $500 million loan facility from Morgan Stanley and expanding its infrastructure to support AI and HPC workloads. This pivot is seen as a core driver for long-term value, despite the acknowledgment that other AI stocks might offer greater upside with less risk.
Is Core Scientific (CORZ) One of the Best Crypto Stocks with Huge Upside Potential?
Core Scientific (CORZ) is transitioning from Bitcoin mining to high-performance computing (HPC) and AI infrastructure, attracting a "Market Outperform" rating from Citizens with a $30 price target. The company secured a $500 million loan facility from Morgan Stanley and is expanding its data center capacity to support this strategic pivot. While Core Scientific shows potential, the article also promotes another "cheapest AI stock" with purportedly higher returns.
Kintayl Capital LP Acquires New Position in Core Scientific, Inc. $CORZ
Kintayl Capital LP has acquired a new position in Core Scientific, Inc. (NASDAQ:CORZ) during the third quarter, purchasing 570,054 shares valued at approximately $10.23 million, making it their 6th largest holding. Several other institutional investors have also adjusted their stakes in Core Scientific, and analysts have issued a mixed but generally positive outlook, with an average "Moderate Buy" rating and a price target of $24.84. Core Scientific, a leading provider of large-scale blockchain infrastructure, reported $0.42 EPS for its last quarter, significantly beating analyst estimates.
What triggered Core Scientific shares' latest price surge
Core Scientific Inc. (CORZ) shares recently surged 2.44%, despite mixed technical signals. This increase is primarily attributed to significant institutional interest, including Jericho Capital Asset Management acquiring over 11 million shares. While some experts caution about mixed momentum, others believe these institutional inflows confirm a bullish long-term outlook for the company.
Jericho Capital Asset Management L.P. Makes New Investment in Core Scientific, Inc. $CORZ
Jericho Capital Asset Management L.P. has acquired a new position in Core Scientific, Inc. ($CORZ), purchasing over 11.6 million shares valued at approximately $209.9 million, making it their 18th largest holding. This investment represents 3.77% of Core Scientific. Analysts have a "Moderate Buy" consensus for Core Scientific, despite recent revenue misses, with the stock trading near $16.49 and a market cap of $5.2 billion.
HighVista Strategies LLC Has $1.35 Million Stake in Core Scientific, Inc. $CORZ
HighVista Strategies LLC reduced its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 58.2% in Q3, now holding shares worth $1.35 million. Despite this, other institutional investors have increased their positions. Analysts currently have a "Moderate Buy" rating on Core Scientific with a consensus target price of $24.84, following several upgrades and price target adjustments.
Core Scientific, Inc. $CORZ Stock Position Increased by Boothbay Fund Management LLC
Boothbay Fund Management LLC significantly increased its stake in Core Scientific (NASDAQ:CORZ) during the third quarter, raising its holdings by 1,596.7% to own 685,570 shares valued at $12.3 million. Core Scientific recently reported mixed quarterly earnings, beating EPS estimates with $0.42 per share but missing revenue forecasts. The company currently has a "Moderate Buy" consensus rating from analysts, with an average price target of $24.84, and several firms have recently raised their price objectives.
Current ratio of Core Scientific, Inc. - Tranche 1 – BOATS:CORZW
This page provides financial data regarding the current ratio of Core Scientific, Inc. - Tranche 1 (BOATS:CORZW) on TradingView. It shows that there is no specific numerical value available for the current ratio at this moment, indicating either a lack of data or that the data was not displayed on the page. The page framework indicates fields for Period, Value, Change, and Change %, suggesting that if data were available, it would be presented in this format.
Van ECK Associates Corp Reduces Position in Core Scientific, Inc. $CORZ
Van ECK Associates Corp significantly reduced its stake in Core Scientific, Inc. (NASDAQ:CORZ) during the third quarter, selling 1,235,569 shares and reducing its total holdings to 990,985 shares valued at $17.78 million. Despite this, Core Scientific exceeded EPS expectations but missed revenue estimates, while analysts maintain a "Moderate Buy" rating with a consensus price target of $24.84. The stock recently traded up 2.4% at $16.63, with a market cap of $5.24 billion.
Core Scientific Earnings Call: AI Pivot Gains Speed
Core Scientific's Q4 earnings call revealed significant progress in its AI colocation strategy, with energized capacity rapidly increasing and the CoreWeave contract hitting scale. Despite strong liquidity and a large development pipeline, the company acknowledged delays in signing new customers and an accounting restatement, indicating a mix of strong execution and areas needing investor scrutiny. The transition from Bitcoin mining to AI infrastructure is underway, but near-term profitability remains tied to successful customer diversification and conversion of energized capacity to billing.
What Core Scientific (CORZ)'s Cadillac F1 Data Center Deal Means For Shareholders
Core Scientific recently announced a multi-year partnership with the Cadillac Formula 1 Team, positioning itself as the Official Data Center Partner. This deal highlights Core Scientific's strategic shift from Bitcoin mining to high-density, hybrid data center solutions for compute-intensive clients. The company secured a new US$500 million loan facility to fund this expansion, but this also introduces refinancing risk and balance sheet pressure for shareholders.
Core Scientific (CORZ) Stock: Insider Buys 7,000 Shares Amid AI Infrastructure Expansion
Core Scientific (CORZ) is actively transitioning from cryptocurrency mining to AI data center infrastructure, with significant capacity expansion and strategic partnerships like the 590MW CoreWeave agreement. Despite this progress, the company faces challenges including delayed customer acquisition and an accounting restatement related to internal control weaknesses. Amid these developments, Director Eric Weiss purchased 7,000 CORZ shares, increasing his stake.
Cadillac Formula 1® Team Joins Forces with Core Scientific as Official Data Center Partner
Core Scientific, a leader in digital infrastructure, has announced a multi-year global partnership with the Cadillac Formula 1® Team, becoming its Official Data Center Partner. Core Scientific will advise on and shape the team's data center infrastructure at its new U.S. headquarters in Indianapolis, focusing on high-density computing for simulation, engineering, manufacturing, and race operations. This collaboration aims to provide a secure, scalable, and optimized infrastructure to support the team's high-demands for its 2026 season and beyond.
Cadillac Formula 1® Team Joins Forces with Core Scientific as Official Data Center Partner
Core Scientific, Inc. has announced a multi-year global partnership with the Cadillac Formula 1® Team, becoming its Official Data Center Partner. Core Scientific will provide strategic consulting, architectural guidance, and optimization expertise for the team's data center infrastructure at its new U.S. headquarters in Indianapolis. This partnership will support high-density computing demands for simulation, engineering, manufacturing, and race operations as the team prepares for its 2026 season.
Inside the data deal powering Cadillac’s new US Formula 1 team
Core Scientific, a leader in digital infrastructure, has announced a multi-year global partnership with the Cadillac Formula 1® Team. Core Scientific will serve as the team's Official Data Center Partner, providing strategic consulting and expertise to build a secure and scalable high-density data center infrastructure for their new U.S. headquarters in Indianapolis. This partnership will support advanced simulation, engineering, manufacturing, and race operations for Cadillac F1's entry into the Formula 1® World Championship.
Core Scientific Inc (CORZ) Trading 3.79% Higher on Mar 10
Core Scientific Inc (CORZ) saw its shares rise by 3.79% on March 10, reaching an intraday high of $15.83 before closing at $15.74. The company's stock is currently 33.41% below its 52-week high and 153.79% above its 52-week low. Wall Street analysts have an average target price of $26.10, indicating a potential upside of 65.89%, and the stock holds an "Outperform" consensus recommendation.
